Usual care vs immunosuppressive withdrawal after monotherapy
Serious adverse events · Participants with Crohn's disease in remission
It is very uncertain whether usual care changes serious adverse events compared with immunosuppressive withdrawal after monotherapy (very low certainty).
1 finding from 1 review
- Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease 2018 · Cochrane Headline outcomes onlyRR 3.29 [0.35, 30.8]2 studies · 134 participantsVery low